Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia
Phase 1
Active, not recruiting
- Conditions
- Osteomalacia
- Registration Number
- NCT03736564
- Lead Sponsor
- Mayo Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Inclusion Criteria:<br><br> - Adults (18 years of age or older) seen at Mayo Clinic, Rochester for FGF23 mediated<br> osteomalacia between 1/1/2000 and 1/30/2018 who provide informed consent to<br> participate in the study.<br><br>Exclusion Criteria:<br><br> - Pregnant<br><br> - Prisoners<br><br> - Subjects diagnosed with heritable hypophosphatemic rickets/osteomalacia<br><br> - Subjects who do not consent for the study or withdraw consent during the duration of<br> the study.<br><br> - Subjects in whom tumor localization and successful resection has already occurred.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 68Ga-DOTATATE PET Positive Maximum Intensity Projection
- Secondary Outcome Measures
Name Time Method